Premium Nahrungsergänzungsmittel | artgerecht

Microalbuminuria: Causes, Diagnosis & Treatment

Microalbuminuria refers to elevated levels of the protein albumin in the urine, serving as an early indicator of kidney damage. It is commonly associated with diabetes and high blood pressure.

Regular tips about health Regular tips about health

Things worth knowing about "Microalbuminuria"

Microalbuminuria refers to elevated levels of the protein albumin in the urine, serving as an early indicator of kidney damage. It is commonly associated with diabetes and high blood pressure.

What is Microalbuminuria?

Microalbuminuria describes an abnormally elevated excretion of the protein albumin in the urine that exceeds the normal range but remains below the detection threshold of conventional urine dipstick tests. The term combines “micro” (small amount), “albumin” (a key blood protein), and “uria” (in the urine). In modern clinical practice, the preferred term is moderately increased albuminuria. It is considered an important early warning sign of kidney damage and an elevated cardiovascular risk.

Reference Values and Definition

Healthy kidneys filter the blood and allow only minimal amounts of albumin to pass into the urine. The following thresholds are clinically relevant:

Normal: less than 30 mg albumin per gram of creatinine in the urine (mg/g) or less than 20 mg per litre
Microalbuminuria (moderately increased): 30 to 300 mg/g creatinine in a spot urine sample or 20 to 200 mg/l in overnight urine
Macroalbuminuria (severely increased): more than 300 mg/g creatinine – indicating advanced kidney disease

Causes

The most common causes of microalbuminuria include:

Diabetes mellitus (type 1 and type 2): Chronically elevated blood sugar damages the small blood vessels in the kidneys (diabetic nephropathy).
Arterial hypertension (high blood pressure): Persistently elevated blood pressure places strain on the kidney vessels and impairs the filtration barrier.
Heart disease: Heart failure and other cardiovascular conditions can affect kidney function.
Inflammatory kidney diseases (glomerulonephritis): Inflammation of the kidney glomeruli leads to increased protein permeability.
Other factors: Obesity, smoking, intense physical exertion, fever, or urinary tract infections may temporarily increase albumin excretion.

Symptoms

Microalbuminuria itself typically causes no noticeable symptoms. It is usually discovered incidentally during routine check-ups or monitoring of underlying conditions such as diabetes or hypertension. Only when kidney damage has progressed significantly (macroalbuminuria) may symptoms such as fluid retention (oedema), foamy urine, fatigue, or weakness appear.

Diagnosis

Diagnosis is made through a urine test. Since individual measurements may be affected by temporary influencing factors, guidelines recommend confirmation of the finding:

Albumin-to-creatinine ratio (ACR): Measured in a first-morning or spot urine sample – the simplest and most reliable method
24-hour urine collection: Precise determination of daily albumin excretion
Repeat testing: At least two out of three measurements within three to six months should show elevated values to confirm the diagnosis

Additional blood tests (creatinine, glomerular filtration rate/GFR), blood pressure measurements, and blood glucose monitoring are performed to identify the underlying condition.

Treatment

Treatment of microalbuminuria is primarily directed at the underlying disease. The goal is to slow the progression of kidney damage and reduce cardiovascular risk:

Optimal blood glucose control: In patients with diabetes, good metabolic management (HbA1c target) is essential.
Blood pressure reduction: Target blood pressure values below 130/80 mmHg are recommended. ACE inhibitors or AT1 receptor blockers (sartans) are particularly effective as they also provide kidney-protective benefits.
Lifestyle modifications: Low-sodium diet, regular physical activity, weight reduction, and smoking cessation.
Pharmacological therapy: SGLT2 inhibitors (e.g. empagliflozin) have demonstrated kidney-protective effects in diabetic nephropathy.
Regular monitoring: Ongoing surveillance of kidney function and albumin-to-creatinine ratio at regular intervals.

Clinical Significance

Microalbuminuria is not only an early sign of kidney damage but is also recognised as an independent risk marker for cardiovascular diseases such as heart attack and stroke. Early detection and treatment can prevent or significantly delay the progression to chronic kidney disease.

References

Kidney Disease: Improving Global Outcomes (KDIGO) - KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 2022.
American Diabetes Association - Standards of Medical Care in Diabetes, Microvascular Complications and Foot Care. Diabetes Care, 2023.
Levey AS, Coresh J. - Chronic kidney disease. The Lancet, 2012; 379(9811):165-180.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.